147
Participants
Start Date
November 17, 2021
Primary Completion Date
November 11, 2022
Study Completion Date
December 23, 2022
Fezolinetant
oral
Placebo
oral
Juno Vesta Clinic Hatta, Matsudo-shi
Mori Ladies Clinic, Fukuoka
SANO Women's Clinic, Fukuoka
Japan Organization of Occupational Health and Safety Kyushu Rosai Hospital, Kitakyusyu-shi
Ena Odori Clinic, Sapporo
Kotoni Ladies Clinic, Sapporo
M's Ladies Clinic, Sapporo
Nishikawa Women's Health Clinic, Sapporo
Sapporo Medical Center, NTT East Corporation, Sapporo
Tonan Hospital, Sapporo
Asahi-Clinic, Takamatsu
Unoki Clinic, Kagoshima
Yoshinaga Women's Clinic, Kagoshima
Sophia Ladies Clinic, Sagamihara-shi
Tawada Ladies Clinic, Yokohama
Women's Clinic LUNA Yokohama Motomachi, Yokohama
Kyoto City Hospital, Kyoto
Chieko Yukika Lady's Clinic, Sendai
Social Medical Care Corporation Hosei-kai Marunouchi Hospital, Matsumoto-shi
Kurashiki Medical Clinic, Kurashiki-shi
GyNet Medical Corporation Minamimorimachi Ladies' Clinic, Osaka
Nomura Clinic Namba, Osaka
jMOG Medical Corporation Tanabe Ladies' Clinic, Takatsuki-shi
Maruyama Memorial General Hospital, Saitama-shi
Omi Medical Center, Social Medical Corporation Seikoukai, Kusatsu-shi
Omihachiman Community Medical Center, Ōmihachiman
Hamada Hospital, Chiyoda-ku
Ginza Yoshida Clinic, Chuo-Ku
Medical Corporation Asbo Tokyo Asbo Clinic, Chuo-ku
Medical Corp. SEIKOUKAI New Medical Research System Clinic, Hachioji-shi
Toranomon Womens Clinic, Minato-ku
Yokokura Clinic, Minato-ku
Shimamura Memorial Hospital, Nerima-ku
Yukawa Women's Clinic, Nishi-Tokyo-shi
Seijo Kinoshita Hospital, Setagaya-ku
Ikebukuro Clinic, Toshima-ku
Ikebukuro Metropolitan Clinic, Toshima-ku
Kurobe City Hospital, Kurobe-shi
Japan Organization of Occupational Health and Safety Toyama Rosai Hospital, Uozu-shi
Japan Community Healthcare Organization Tokuyama Central Hospital, Shunan-shi
Lead Sponsor
Astellas Pharma Inc
INDUSTRY